TrialDigestive diseases and sciences2021

No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.

Stephane Paul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.